Micron Slips Further While Shorts Stay Away

Micron Technology has now fallen 18% from its October 1 peak of $1,097, yet the investors who profit from declines show no sign of pressing the trade.

The stock closed at $896.07 on Tuesday, down 6% on the week and nearly 12% over the past month. That slide is not uniquely a Micron problem. Close peers LRCX and MKSI dropped 12.5% and 14.7% respectively over the same period, while AMD and AMAT each fell more than 11%. The semiconductor complex has been under broad pressure, and Micron has moved largely in line with its peer group rather than underperforming it.

The positioning story continues to argue against a structural break. Short interest ticked up fractionally this week, rising 1.6% to 25.5 million shares, or 2.27% of the free float. That level is still lower than where it stood through most of September, when shorts held more than 29 million shares. Bears have net covered roughly 5 million shares since mid-September into a drawdown that now exceeds 18%. Borrowing conditions reinforce the picture: cost to borrow has collapsed 59% on the week to just 0.13%, an annual low. Availability is at the data ceiling, with more than a billion shares available to lend against a short book of 25 million. Options positioning is similarly relaxed, with the put/call ratio at 1.00, just below its 20-day average of 1.02 and sitting at the bottom of its 52-week range. None of the instruments traders use to express a bearish view are being loaded.

The Street is firmly onside, though targets vary widely. Morgan Stanley reiterates Overweight at $1,200, while DA Davidson raised its target to $3,000 on October 7, a figure that stands well above the consensus. The mean price target across active coverage is $1,561, roughly 74% above Tuesday's close. That gap is wide by any measure, and it has widened further as the stock has retreated. The bull case centres on AI-driven memory demand outrunning supply through 2027 and 2028, with F4Q26 revenue up 379% year-over-year to $54.2 billion and adjusted free cash flow of $33.2 billion. The bear case is more structural: memory is cyclical, the geopolitical exposure across Taiwan, Singapore and China is genuine, and any demand stumble would hit revenue hard. On valuation, the trailing PE has compressed to 4.5x and EV/EBITDA to 3.4x, both down sharply over the past 30 days as earnings estimates have held while the price has fallen. EPS momentum ranks in the 97th percentile on a 90-day basis. The ORTEX stock score recently sat at 98.5, close to the ceiling of its range.

Retail attention is also picking up. The ORTEX Wikipedia views signal has a z-score of 1.96 against Micron's own 90-day history, the highest recent reading. That captures search and page-view traffic, not a revenue indicator, but it suggests the drawdown is generating public interest rather than being ignored.

Institutional holders have been adding. BlackRock reported 104.8 million shares at September 30, up 1.7 million from the prior quarter. JP Morgan Asset Management added 8 million shares in the same period. On the insider side, most of the recent activity is noise: sales by the President and Chief Legal Officer in October were all executed under pre-arranged 10b5-1 plans, which are scheduled well in advance and carry limited informational weight. The 90-day net insider position is negative at roughly $31.6 million sold, but the composition matters more than the headline.

The next earnings event is December 16. With 56 days to the print, the question resolves around whether the valuation gap of roughly 74% to consensus target narrows from the price side, the estimate side, or neither.